should read:
'A more recent review of this patient group (median follow-up 141 days) reported that 13 patients, four without prior brain irradiation, continued on study treatment without progression (reported in an abstract) [23] .' Page 80, figure 4 legend, lines 5 and 6.
The figure legend that previously read:
'Treatment-related adverse events associated with twicedaily alectinib 300 mg in patients with ALK-rearranged advanced non-small cell lung cancer. Adverse events reported in C10 % of patients (n = 46) in the phase 2 portion of a phase 1-2 study [18] . ALP alanine phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, CPK creatinine phosphokinase.' should read:
'Treatment-related adverse events associated with twicedaily alectinib 300 mg in patients with ALK-rearranged advanced non-small cell lung cancer. Adverse events reported in C10 % of patients (n = 46) in the phase 2 portion of a phase 1-2 study [18] . ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, CPK creatine phosphokinase.'
